MiMedx Group, Inc

MiMedx® is a biopharmaceutical company developing, manufacturing and marketing regenerative biologics utilizing human placental allografts for multiple sectors of healthcare. “Innovations in Regenerative Medicine” is the framework behind our mission to provide physicians with products and tissues to help the body heal itself.We process human placental tissue utilizing our proprietary PURION® process methodology, among other processes, to produce safe and effective allografts by employing aseptic processing techniques in addition to terminal sterilization.


Bank Name MiMedx Group, Inc
Stock Exchange NASDAQ
Symbol MDXG
Sector Healthcare
Industry Medical/Dental Instruments
Country United States
World Region Amarica
Chairman Mr. Parker H. Petit
CEO Mr. Parker H. Petit
Employees 690
Website www.mimedx.com
Registered Year